机构:[1]Department of Minimally Invasive Spine Surgery, Luoyang Orthopedic Hospital of Henan Province, Zhengzhou City, Henan, 450018, China[2]Integrated Orthopedic Department of Traditional Chinese Medicine (TCM) and Western Medicine Hong-Hui Hospital, Xi’an Jiaotong University College of Medicine, Xi’an City, Shaanxi, 710054, China[3]Deparment of Orthopedics, Beijing Tongren Hospital, Biejing, China首都医科大学附属北京同仁医院首都医科大学附属同仁医院[4]Department of Orthopedics, Shidong Hospital, Yangpu District, Shanghai, 200438, China
The presented investigation explores the efficiency of novel transdermal drug delivery system of combination of two drugs i.e risedronate and alendronate in the treatment of osteoporosis. The nanoparticulate transdermal patch was prepared using PLGA as principle polymer which has been found to be suitable for drug delivery. The novel formulation system was found to be more efficient in lowering and maintaining the plasma calcium at a normal level when compared to a pure drug in a study carried out on an excised rat skin.
基金:
Shanghai Health and Family Planning Commission [20164Y0050]
第一作者机构:[1]Department of Minimally Invasive Spine Surgery, Luoyang Orthopedic Hospital of Henan Province, Zhengzhou City, Henan, 450018, China
通讯作者:
推荐引用方式(GB/T 7714):
Kong Fanguo,Jia Bin,Cui Peng,et al.Novel combinatorial transdermal drug delivery of alendronate with risedronate for the treatment of osteoporosis[J].ACTA BIOCHIMICA POLONICA.2019,66(4):463-467.doi:10.18388/abp.2019_2863.
APA:
Kong, Fanguo,Jia, Bin,Cui, Peng&Wang, Duojun.(2019).Novel combinatorial transdermal drug delivery of alendronate with risedronate for the treatment of osteoporosis.ACTA BIOCHIMICA POLONICA,66,(4)
MLA:
Kong, Fanguo,et al."Novel combinatorial transdermal drug delivery of alendronate with risedronate for the treatment of osteoporosis".ACTA BIOCHIMICA POLONICA 66..4(2019):463-467